Research-led advances in healthcare practices sometimes requires the acquisition of new technology. One recent example is the adoption of new guidelines on stroke assessment protocols in the Netherlands following integration of results from the MR CLEAN study
1 – a trial of intra-arterial treatment for acute ischemic stroke, and the MR CLEAN-LATE study
2. These studies provided new insights in the treatment of ischemic stroke made possible through the use of CT brain perfusion after brain infarctions. This imaging technique was found to give a good indication of brain tissue status before deciding the best options for neuro intervention or thrombolysis.
With the introduction of new protocols across the Netherlands in 2021, the Groene Hart Ziekenhuis (GHZ) in Gouda, the Netherlands, was able to fulfill the new guidelines thanks to Canon Medical technology. Stijn Bollen, Radiologist, and Melissa van den Bos, Medical Physicist Expert at the GHZ, explain how the systems and software assist their work.
GHZ is a general hospital that offers state-of-the-art medical care from four different locations, from which Gouda is the main location (Gouda, Bodegraven, Schoonhoven, and Zuidplas) all of which lie within the “Groene Hart” (Green Heart) area of the Netherlands. It has two Canon Medical Aquilion Prime SP CT scanners with Vitrea Advanced Visualization and Automation Platform.
“At the end of 2021, we implemented the brain perfusion CT protocol in addition to CT angiography for detecting acute infarctions and calculating the percentage of penumbra and core, to follow the new updated Dutch guidelines,” said Stijn. “With implementation of this new protocol, we also started to use the Automation Platform from Canon Medical to confirm the diagnosis of ischemic stroke and to estimate tissue viability.”
“During the day and night, we scan patients with symptoms of brain infarction, therefore, we make use of Canon Medical’s Automation Platform,” added Stijn.